CN101417912B - 制备倍他米松醋酸酯的方法 - Google Patents
制备倍他米松醋酸酯的方法 Download PDFInfo
- Publication number
- CN101417912B CN101417912B CN2008102024772A CN200810202477A CN101417912B CN 101417912 B CN101417912 B CN 101417912B CN 2008102024772 A CN2008102024772 A CN 2008102024772A CN 200810202477 A CN200810202477 A CN 200810202477A CN 101417912 B CN101417912 B CN 101417912B
- Authority
- CN
- China
- Prior art keywords
- acetate
- reaction
- formula
- solvent
- ammonium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims abstract description 24
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 title claims description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 35
- 238000006243 chemical reaction Methods 0.000 claims abstract description 34
- 239000000047 product Substances 0.000 claims abstract description 13
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 12
- 150000003863 ammonium salts Chemical class 0.000 claims abstract description 11
- 239000003444 phase transfer catalyst Substances 0.000 claims abstract description 8
- 239000007787 solid Substances 0.000 claims abstract description 7
- 230000003197 catalytic effect Effects 0.000 claims abstract description 5
- 239000007795 chemical reaction product Substances 0.000 claims abstract description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical group BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims description 8
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 7
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical group N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 7
- 239000005695 Ammonium acetate Substances 0.000 claims description 7
- 229940043376 ammonium acetate Drugs 0.000 claims description 7
- 235000019257 ammonium acetate Nutrition 0.000 claims description 7
- 229910052740 iodine Chemical group 0.000 claims description 7
- 239000011630 iodine Chemical group 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- VQKFNUFAXTZWDK-UHFFFAOYSA-N 2-Methylfuran Chemical compound CC1=CC=CO1 VQKFNUFAXTZWDK-UHFFFAOYSA-N 0.000 claims description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical group [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 3
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 claims description 3
- 239000001632 sodium acetate Substances 0.000 claims description 3
- 229960004249 sodium acetate Drugs 0.000 claims description 3
- 235000017281 sodium acetate Nutrition 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 2
- 235000019270 ammonium chloride Nutrition 0.000 claims description 2
- LDDQLRUQCUTJBB-UHFFFAOYSA-N ammonium fluoride Chemical compound [NH4+].[F-] LDDQLRUQCUTJBB-UHFFFAOYSA-N 0.000 claims description 2
- XJMWHXZUIGHOBA-UHFFFAOYSA-N azane;propanoic acid Chemical compound N.CCC(O)=O XJMWHXZUIGHOBA-UHFFFAOYSA-N 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 238000006555 catalytic reaction Methods 0.000 claims description 2
- 239000000460 chlorine Chemical group 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 125000001153 fluoro group Chemical group F* 0.000 claims description 2
- 239000007791 liquid phase Substances 0.000 claims description 2
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 claims description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 1
- 239000007788 liquid Substances 0.000 abstract description 10
- 238000002360 preparation method Methods 0.000 abstract description 9
- 229960004648 betamethasone acetate Drugs 0.000 abstract description 2
- AKUJBENLRBOFTD-QZIXMDIESA-N betamethasone acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(C)=O)(O)[C@@]1(C)C[C@@H]2O AKUJBENLRBOFTD-QZIXMDIESA-N 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 18
- 239000012074 organic phase Substances 0.000 description 16
- 238000010992 reflux Methods 0.000 description 12
- 238000005406 washing Methods 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 238000013019 agitation Methods 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000012065 filter cake Substances 0.000 description 4
- 229910017053 inorganic salt Inorganic materials 0.000 description 4
- 238000002386 leaching Methods 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000007670 refining Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 3
- 235000019439 ethyl acetate Nutrition 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 239000013067 intermediate product Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 125000002346 iodo group Chemical group I* 0.000 description 2
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 description 1
- 206010000830 Acute leukaemia Diseases 0.000 description 1
- AKUJBENLRBOFTD-DKNQJTFPSA-N C[C@@H](CC(C(CCC([C@]1(C)C=C2)=CC2=O)[C@@]11F)[C@]2(C)C[C@@H]1O)[C@@]2(C(COC(C)=O)=O)O Chemical compound C[C@@H](CC(C(CCC([C@]1(C)C=C2)=CC2=O)[C@@]11F)[C@]2(C)C[C@@H]1O)[C@@]2(C(COC(C)=O)=O)O AKUJBENLRBOFTD-DKNQJTFPSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229960002537 betamethasone Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940087110 celestone Drugs 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102024772A CN101417912B (zh) | 2008-11-10 | 2008-11-10 | 制备倍他米松醋酸酯的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102024772A CN101417912B (zh) | 2008-11-10 | 2008-11-10 | 制备倍他米松醋酸酯的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101417912A CN101417912A (zh) | 2009-04-29 |
CN101417912B true CN101417912B (zh) | 2012-11-14 |
Family
ID=40628937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008102024772A Active CN101417912B (zh) | 2008-11-10 | 2008-11-10 | 制备倍他米松醋酸酯的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101417912B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101544544A (zh) * | 2009-05-05 | 2009-09-30 | 池州万维化工有限公司 | 一种4-溴-3,5-二甲基苯酚的制备方法 |
CN102746358B (zh) * | 2011-04-22 | 2016-02-10 | 天津金耀集团有限公司 | 一种合成孕甾21位溴化物的工艺 |
US8580886B2 (en) * | 2011-09-20 | 2013-11-12 | Dow Corning Corporation | Method for the preparation and use of bis (alkoxysilylorgano)-dicarboxylates |
CN102659887B (zh) * | 2012-05-14 | 2013-06-19 | 西安高远生化有限责任公司 | 一种倍他米松戊酸酯的合成方法 |
CN104059120A (zh) * | 2014-05-27 | 2014-09-24 | 上海新华联制药有限公司 | 一种高纯度倍他米松醋酸酯制备工艺 |
CN108264531B (zh) * | 2016-12-30 | 2022-08-09 | 上海市农药研究所有限公司 | 一种醋酸阿奈可他的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB906443A (en) * | 1958-03-19 | 1962-09-19 | Merck & Co Inc | Steroid compounds |
US3164618A (en) * | 1957-07-22 | 1965-01-05 | Schering Corp | Alkylated steroids |
-
2008
- 2008-11-10 CN CN2008102024772A patent/CN101417912B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3164618A (en) * | 1957-07-22 | 1965-01-05 | Schering Corp | Alkylated steroids |
GB906443A (en) * | 1958-03-19 | 1962-09-19 | Merck & Co Inc | Steroid compounds |
Non-Patent Citations (2)
Title |
---|
Nicholas I. Carruthers, et al..Synthesis of Corticoids from 9α-Hydroxyandrost-4-ene-3,17-dione.《J. Org. Chem.》.1992,第57卷(第3期),第961-965页. * |
NicholasI.Carruthers et al..Synthesis of Corticoids from 9α-Hydroxyandrost-4-ene-3 |
Also Published As
Publication number | Publication date |
---|---|
CN101417912A (zh) | 2009-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101417912B (zh) | 制备倍他米松醋酸酯的方法 | |
CN107129516B (zh) | 黄体酮的制备方法 | |
CN102268058B (zh) | 制备17α-羟基孕酮或其类似物的方法 | |
CN101418029B (zh) | 甲基强龙的合成方法 | |
CN102367262B (zh) | 一种氢化可的松的制备方法 | |
CN102786448A (zh) | 一种合成belinostat的方法 | |
CN101418032A (zh) | 地夫可特的合成方法 | |
CN102603843A (zh) | 一种地塞米松中间体的制备方法 | |
CN102206151B (zh) | 王浆酸的合成方法 | |
CN102827231A (zh) | 一种氢化可的松的制备工艺 | |
CN103360411B (zh) | 依维莫司结晶提纯方法 | |
JP6714062B2 (ja) | アゾキシストロビンの調製方法 | |
CN101397322B (zh) | 去羟米松的制备 | |
CN106397516B (zh) | 坎格雷洛中间体及其制备方法和应用 | |
CN101973932A (zh) | 一种比沙可啶的制备方法 | |
CN102584928A (zh) | 一种反式甘草酸的制备方法 | |
CN100549022C (zh) | 制备氟替卡松丙酸酯的方法 | |
CN101362752B (zh) | 一种拉米夫定中间体的合成方法 | |
CN103396468B (zh) | 一种醋酸泼尼松龙的制备方法 | |
CN104557899A (zh) | 一种阿齐沙坦i晶型晶体的制备方法 | |
CN104788429A (zh) | 一种通过脱除三苯甲基保护基制备沙坦类药物的方法 | |
CN104447724B (zh) | 一种雷替曲塞的精制方法 | |
CN104030941B (zh) | 一种3-(4-羟基苯基)丙酰胺的合成方法 | |
CN103641879A (zh) | 泼尼松龙中间体或其类似物的制备方法 | |
CN100368375C (zh) | 3-烷氧基-4-烷氧羰基苯乙酸酯及3-烷氧基-4-烷氧羰基苯乙酸的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: Shaoyang City, Hunan Province, 422000 dragon pond Applicant after: HUNAN YUXIN PHARMACEUTICAL CO.,LTD. Address before: Shaoyang City, Hunan Province, 422000 dragon pond Applicant before: Hunan Steroidchem Pharmaceutical Co.,Ltd. |
|
CB03 | Change of inventor or designer information |
Inventor after: Shen Yuliang Inventor after: Cao Chunyu Inventor after: Zheng Liangbin Inventor after: Liu Hong Inventor after: Shu Zhijian Inventor before: Liu Xirong Inventor before: Xie Laibin Inventor before: Hu Aiguo |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU XIRONG XIE LAIBIN HU AIGUO TO: SHEN YULIANG CAO CHUNYU ZHENG LIANGBIN LIU HONG SHU ZHIJIAN Free format text: CORRECT: APPLICANT; FROM: HUNAN STEROID CHEMICALS CO., LTD. TO: HU'NAN YUXIN PHARMACEUTICAL CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for preparing becort acetate Effective date of registration: 20171226 Granted publication date: 20121114 Pledgee: Credit Company Limited by Guarantee of small and medium enterprises in Shaoyang Pledgor: HUNAN YUXIN PHARMACEUTICAL CO.,LTD. Registration number: 2017430000121 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221223 Granted publication date: 20121114 Pledgee: Credit Company Limited by Guarantee of small and medium enterprises in Shaoyang Pledgor: HUNAN YUXIN PHARMACEUTICAL CO.,LTD. Registration number: 2017430000121 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for preparing betamethasone acetate Effective date of registration: 20230103 Granted publication date: 20121114 Pledgee: Shaoyang small and medium-sized enterprise financing guarantee Co.,Ltd. Pledgor: HUNAN YUXIN PHARMACEUTICAL CO.,LTD. Registration number: Y2023980030141 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |